Trials / Completed
CompletedNCT02434744
Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- Response Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare the safety, tolerability and efficacy of the combination of KD026 and metformin compared to placebo and metformin on improving glycemic control in patients with type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KD026 | Dosed in combination |
| DRUG | Placebo | Dosed in combination |
| DRUG | Metformin | Drug prescribed by each subject's prescribing physician |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2015-05-05
- Last updated
- 2023-11-18
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02434744. Inclusion in this directory is not an endorsement.